Minu Dutia

1.1k total citations
21 papers, 908 citations indexed

About

Minu Dutia is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Minu Dutia has authored 21 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Minu Dutia's work include Synthesis and biological activity (7 papers), Melanoma and MAPK Pathways (7 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Minu Dutia is often cited by papers focused on Synthesis and biological activity (7 papers), Melanoma and MAPK Pathways (7 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Minu Dutia collaborates with scholars based in United States and Canada. Minu Dutia's co-authors include Jonathan D. Bloom, Elwood Largis, Allan Wissner, Dennis Powell, Michael Burns, Thomas H. Claus, Frank Boschelli, Diane H. Boschelli, Biqi Wu and Jennifer M. Weber and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Minu Dutia

21 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minu Dutia United States 14 429 336 184 123 99 21 908
Marie A. Holahan United States 22 278 0.6× 173 0.5× 121 0.7× 115 0.9× 290 2.9× 50 1.1k
Roland Feifel Switzerland 21 769 1.8× 338 1.0× 75 0.4× 164 1.3× 55 0.6× 36 1.3k
Srikant Viswanadha United States 18 348 0.8× 95 0.3× 76 0.4× 137 1.1× 68 0.7× 65 795
Peppi Prasit United States 21 592 1.4× 242 0.7× 234 1.3× 126 1.0× 19 0.2× 44 1.2k
Péter Arányi Hungary 17 305 0.7× 127 0.4× 36 0.2× 48 0.4× 48 0.5× 76 753
Naina Patel United Kingdom 18 482 1.1× 73 0.2× 152 0.8× 178 1.4× 77 0.8× 32 1.1k
Geeta Patel United Kingdom 18 288 0.7× 224 0.7× 49 0.3× 166 1.3× 102 1.0× 45 732
Inge M. Michel United States 18 412 1.0× 103 0.3× 96 0.5× 75 0.6× 124 1.3× 45 870
Hiroshi Kayakiri Japan 20 611 1.4× 617 1.8× 79 0.4× 106 0.9× 76 0.8× 43 1.3k
Ying K. Yee United States 16 275 0.6× 291 0.9× 254 1.4× 58 0.5× 27 0.3× 24 885

Countries citing papers authored by Minu Dutia

Since Specialization
Citations

This map shows the geographic impact of Minu Dutia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minu Dutia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minu Dutia more than expected).

Fields of papers citing papers by Minu Dutia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minu Dutia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minu Dutia. The network helps show where Minu Dutia may publish in the future.

Co-authorship network of co-authors of Minu Dutia

This figure shows the co-authorship network connecting the top 25 collaborators of Minu Dutia. A scholar is included among the top collaborators of Minu Dutia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minu Dutia. Minu Dutia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaolun, Dan M. Berger, Edward J. Salaski, et al.. (2010). Indazolylpyrazolopyrimidine as Highly Potent B-Raf Inhibitors with in Vivo Activity. Journal of Medicinal Chemistry. 53(21). 7874–7878. 14 indexed citations
2.
Grandi, Martin J. Di, Dan M. Berger, Darrin W. Hopper, et al.. (2009). Novel pyrazolopyrimidines as highly potent B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(24). 6957–6961. 27 indexed citations
3.
Berger, Dan M., Minu Dutia, Dennis Powell, et al.. (2009). Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6519–6523. 32 indexed citations
4.
Berger, Dan M., Minu Dutia, Dennis Powell, et al.. (2008). 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors. Bioorganic & Medicinal Chemistry. 16(20). 9202–9211. 16 indexed citations
5.
Mayer, Scott C., Dan M. Berger, Diane H. Boschelli, et al.. (2008). Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorganic & Medicinal Chemistry Letters. 19(1). 62–66. 34 indexed citations
6.
Wang, Yanong D., Minu Dutia, M. Brawner Floyd, et al.. (2008). Synthesis of 7-(E)-alkenyl-4-amino-3-quinolinecarbonitriles via Pd-mediated Heck, Stille, and Suzuki reactions. Tetrahedron. 65(1). 57–61. 11 indexed citations
7.
Hopper, Darrin W., Minu Dutia, Dan M. Berger, & Dennis Powell. (2007). Observation of differential reactivity of cyclic amines in SN2 and SNAr displacement reactions in the course of synthesizing C-6, C-7 substituted quinolinecarbonitrile MEK1 kinase inhibitors. Tetrahedron Letters. 49(1). 137–140. 7 indexed citations
8.
Berger, Dan, Minu Dutia, Dennis Powell, et al.. (2003). Synthesis and evaluation of 4-Anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade. Bioorganic & Medicinal Chemistry Letters. 13(18). 3031–3034. 25 indexed citations
9.
10.
Talpaz, Moshe, et al.. (2002). Novel Tyrosine Kinase Inhibitors Suppress BCR-ABL Signaling and Induce Apoptosis in STI-571 Sensitive and Resistant CML Cells. Blood. 100(11). 143416. 4 indexed citations
11.
Berger, Dan, Minu Dutia, Dennis Powell, et al.. (2002). 8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src Kinase Inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(19). 2761–2765. 8 indexed citations
12.
Berger, Dan, Minu Dutia, Dennis Powell, et al.. (2002). Substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles as Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(20). 2989–2992. 18 indexed citations
13.
Boschelli, Diane H., Yanong D. Wang, Fei Ye, et al.. (2001). Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitriles. Journal of Medicinal Chemistry. 44(5). 822–833. 72 indexed citations
14.
Boschelli, Diane H., Fei Ye, Yanong D. Wang, et al.. (2001). Optimization of 4-Phenylamino-3-quinolinecarbonitriles as Potent Inhibitors of Src Kinase Activity. Journal of Medicinal Chemistry. 44(23). 3965–3977. 179 indexed citations
15.
Berger, Dan, Minu Dutia, Lee M. Greenberger, et al.. (1999). Novel Multidrug Resistance Reversal Agents. Journal of Medicinal Chemistry. 42(12). 2145–2161. 60 indexed citations
16.
Burns, Michael, Claire M. Fraser, A. Donny Strosberg, et al.. (1994). Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines.. Journal of Pharmacology and Experimental Therapeutics. 269(3). 1000–1006. 72 indexed citations
17.
18.
Bloom, Jonathan D., et al.. (1989). Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analogs. Journal of Medicinal Chemistry. 32(10). 2318–2325. 24 indexed citations
19.
Largis, Elwood, et al.. (1986). Potential antiatherosclerotic agents. 5. An acyl-coenzyme A:cholesterol O-acyltransferase inhibitor with hypocholesterolemic activity. Journal of Medicinal Chemistry. 29(7). 1131–1133. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie A. Holahan Breakdown of academic impact, for papers by Roland Feifel Breakdown of academic impact, for papers by Srikant Viswanadha Breakdown of academic impact, for papers by Peppi Prasit Breakdown of academic impact, for papers by Péter Arányi Breakdown of academic impact, for papers by Naina Patel Breakdown of academic impact, for papers by Geeta Patel Breakdown of academic impact, for papers by Inge M. Michel Breakdown of academic impact, for papers by Hiroshi Kayakiri Breakdown of academic impact, for papers by Ying K. Yee
Rankless by CCL
2026